Facebook
Instagram
Linkedin
Youtube
Start
News
Studio
Events
Newsletter
About BioStock
Contact us
Career
Search
BioStock
Start
News
Studio
Events
Newsletter
About BioStock
Contact us
Career
Home
Search
Chordate
-
search results
If you're not happy with the results, please do another search
Chordate comments on Q4 and case report
3 April, 2024
Chordate’s CEO presented at Swiss Nordic Bio
12 March, 2024
Chordate continues its marketing activities and exit strategy
4 January, 2024
Chordate’s CSO comments on the start of the PM009 study
6 December, 2023
Chordate installs system in Germany and launches in the UAE
29 November, 2023
Chordate Medical starts post-market study in four markets
13 November, 2023
Chordate Medical’s migraine treatment gets attention at congress
23 October, 2023
Chordate Medical trains leading UK neurology hospital
11 October, 2023
Chordate Medical launches the trademark Ozilia
12 September, 2023
International specialist congress and upcoming milestones for Chordate Medical
22 August, 2023
Dr Hoffmann presented Chordate Medical’s results in the US
12 July, 2023
Otto Skolling elected to Chordate Medical’s Board
15 June, 2023
Chordate’s treatment has effect on allergic rhinitis
9 June, 2023
The market in Saudi Arabia opens up for Chordate
11 May, 2023
Clinical Trial Investigator in Chordate’s study in chronic migraine
21 April, 2023
Chordate presents study results for the American Headache Society
19 April, 2023
Market update Chordate Medical: “We have a favourable position”
13 April, 2023
Chordate’s CEO on entering new markets
22 March, 2023
BioStock Investor Meeting starts today at 10.00
16 March, 2023
Chordate makes progress in Italy, China and Saudi Arabia
2 March, 2023
BioStock Investor Meeting 2023
10 February, 2023
Watch the BioStock Life Science Fall Summit!
8 December, 2022
Chordate Medical reports Q3 and carries out rights issue
21 November, 2022
Chordate’s migraine study paves way for planned exit
4 November, 2022
Chordate could contribute to migraine care in Sweden
21 October, 2022
Chordate introduces migraine treatment in Finland
11 October, 2022
Dr Hoffmann presents results from Chordate’s migraine study
9 September, 2022
Chordate accelerates global market entry
2 September, 2022
BioStock Life Science Fall Summit 2022
16 August, 2022
Chordate sums up H1 and projects sales growth
8 July, 2022
Chordate’s CSO is looking forward to migraine study results
13 June, 2022
Watch day 2 of the BioStock Life Science Spring Summit
9 June, 2022
The BioStock Life Science Spring Summit starts now
8 June, 2022
BioStock Life Science Spring Summit, June 8-9, 2022
26 March, 2022
Chordate Medical opens representative office in Saudi Arabia
17 March, 2022
Chordate Medical’s CEO on the marketing and sales plans
7 March, 2022
Chordate Medical’s CEO on UK market introduction
17 February, 2022
Chordate enters 2022 with strong confidence
4 February, 2022
Chordate Medical closed 2021 with focus on Saudi Arabia
3 January, 2022
Chordate Medical secures entrance to Chinese market
9 December, 2021
Successful outcome of Chordate Medical’s warrant
4 November, 2021
Chordate Medical’s migraine study enters final stage
22 October, 2021
Join us for the BioStock Life Science Summit on October 20...
20 October, 2021
Chordate Medical’s CEO on US marketing plans
15 October, 2021
Chordate Medical strengthens its Board of Directors
8 October, 2021
Market report predicts strong growth for Chordate Medical’s technology
23 September, 2021
Chordate Medical resumes initiative with Nanos Medical in China
7 September, 2021
Chordate Medical got the ball rolling in the second quarter
1 September, 2021
Italian doctor sees great potential in Chordate Medical’s treatment
17 August, 2021
Chordate Medical’s method treats without surgery or drugs
4 July, 2021
Chordate Medical notified on when to resume migraine study
2 July, 2021
Chordate Medical’s CEO on advancement in Saudi Arabia
2 July, 2021
Chordate Medical’s CEO comments on recent successes and future plans
28 June, 2021
Italian distributor expresses confidence in Chordate Medical’s migraine treatment
3 June, 2021
Innovation in focus at BioStock Life Science Spring Summit 2021
25 May, 2021
Chordate Medical’s CEO on CE marking in chronic migraine
12 May, 2021
Large shareholders discuss their increased holdings in Chordate Medical
26 February, 2021
Restart for Chordate Medical’s migraine study
24 February, 2021
Chordate Medical wants to treat one of Sweden’s most widespread diseases
12 February, 2021
Eventful 2020 on many levels for Chordate Medical
21 December, 2020
1
2
Page 1 of 2
